The Fenlix Motor: A Validated Computational Pipeline for Kinase Inhibitor Selectivity Prediction — Four Disease Cases, One Geometric Principle

Read full text Summarise with VIRAT
Authors: Andres Pirolo
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Four diseases. Four candidates. One principle. The Fenlix Motor — a three-stage computational pipeline for kinase inhibitor selectivity prediction — has identified minimal structural modifications that produce consistent selectivity improvements across four independent disease targets: pancreatic cancer (KRAS G12D), Chagas disease (TcCLK1), antiarrhythmic toxicity reduction (DYRK1B), and autism spectrum disorder (DYRK1A/CDK5). The pattern that emerges is geometric: in three of four cases, a functional group at the meta (3) position of the distal aromatic ring reaches non-conserved hinge residues at the optimal distance (4.0–4.5 Å) for productive non-covalent interactions. The ortho position is sterically blocked. The para position reaches solvent. The meta position reaches the hinge. Four candidates identified: B02_3F (1.34×), E02_3NH2 (1.24×), A01_2Br (1.23×), B01_noEt (1.25×). Each differs from its reference compound by one atom or one functional group. Each prediction is crystallographically anchored in RCSB PDB structures. The complete pipeline runs on accessible mobile hardware at zero cost. No institutional infrastructure required. Academic use: unrestricted. Commercial use: written authorization required. Contact: apirolo@abc.gob.ar

Fields of Study & Subjects

Computational Drug Discovery Methods Protein Degradation and Inhibitors Protein Kinase Regulation and GTPase Signaling

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
27 March 2026
Language
EN
Document type
Preprint